HK1139332A1 - Chemically stable compositions of 4-hydroxy tamoxifen 4- - Google Patents

Chemically stable compositions of 4-hydroxy tamoxifen 4-

Info

Publication number
HK1139332A1
HK1139332A1 HK10106178.9A HK10106178A HK1139332A1 HK 1139332 A1 HK1139332 A1 HK 1139332A1 HK 10106178 A HK10106178 A HK 10106178A HK 1139332 A1 HK1139332 A1 HK 1139332A1
Authority
HK
Hong Kong
Prior art keywords
chemically stable
stable compositions
hydroxy tamoxifen
tamoxifen
hydroxy
Prior art date
Application number
HK10106178.9A
Other languages
English (en)
Chinese (zh)
Inventor
Dana C Hilt
Valrie Masini-Eteve
Richard Fedynec
Brigitte Taravella
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of HK1139332A1 publication Critical patent/HK1139332A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10106178.9A 2004-03-22 2010-06-23 Chemically stable compositions of 4-hydroxy tamoxifen 4- HK1139332A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290762A EP1579857A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen
US10/805,530 US20050208139A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen

Publications (1)

Publication Number Publication Date
HK1139332A1 true HK1139332A1 (en) 2010-09-17

Family

ID=34854723

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07104159.2A HK1098674A1 (en) 2004-03-22 2007-04-20 Chemically stable compositions of 4-hydroxy tamoxifen
HK10106178.9A HK1139332A1 (en) 2004-03-22 2010-06-23 Chemically stable compositions of 4-hydroxy tamoxifen 4-

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK07104159.2A HK1098674A1 (en) 2004-03-22 2007-04-20 Chemically stable compositions of 4-hydroxy tamoxifen

Country Status (22)

Country Link
US (1) US20050208139A1 (xx)
EP (4) EP1579857A1 (xx)
JP (1) JP5489407B2 (xx)
CN (1) CN101080222B (xx)
AR (1) AR048587A1 (xx)
AT (1) ATE453387T1 (xx)
AU (1) AU2005227073B2 (xx)
CA (1) CA2557806C (xx)
DE (1) DE602005018613D1 (xx)
DK (1) DK1727532T3 (xx)
ES (3) ES2402921T3 (xx)
HK (2) HK1098674A1 (xx)
IL (2) IL177778A (xx)
MX (1) MXPA06010928A (xx)
NO (1) NO337298B1 (xx)
NZ (1) NZ549664A (xx)
PL (1) PL1727532T3 (xx)
PT (1) PT1727532E (xx)
RU (1) RU2389483C2 (xx)
TW (1) TWI401078B (xx)
WO (1) WO2005092310A2 (xx)
ZA (1) ZA200607291B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087123A1 (en) * 2003-04-01 2004-10-14 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
WO2004054557A2 (en) 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
DE60327363D1 (de) * 2002-12-18 2009-06-04 Besins Int Lab Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
CA2528431C (en) * 2003-06-09 2012-09-18 Northwestern University Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US7968532B2 (en) 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
MX2007004371A (es) * 2004-10-14 2007-06-07 Besins Int Lab Formulaciones de 4-hidroxitamoxifen en gel.
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
CA2775266C (en) * 2009-10-13 2013-12-31 Duquesne University Of The Holy Spirit, A Nonprofit Corporation Organized Under The Laws Of The Commonwealth Of Pennsylvania Anti-cancer tamoxifen-melatonin hybrid ligand
WO2013010137A2 (en) * 2011-07-14 2013-01-17 Jacks Health Technologies Llc A composition, device and method for delayed and sustained release of brain energy molecules

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
US5475851A (en) * 1986-04-14 1995-12-12 National Instruments Corporation Method and apparatus for improved local and global variable capabilities in a graphical data flow program
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
CA2032695A1 (en) 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5809266A (en) * 1994-07-29 1998-09-15 Oracle Corporation Method and apparatus for generating reports using declarative tools
DE4435784C2 (de) * 1994-10-06 1998-10-29 Heraeus Electro Nite Int Elektrisch beheizbarer Starterkat
US5777621A (en) * 1994-12-22 1998-07-07 Apple Computer, Inc. Quality control mechanism for three-dimensional graphics rendering
HUP9900951A3 (en) * 1996-01-20 2000-02-28 Bradford University Bradford Process for producing tamoxifen and analogues thereof
EP0907351B2 (de) * 1996-03-29 2012-04-18 Keyvest GmbH Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
AU2513899A (en) * 1997-12-23 1999-07-19 Hexal Ag Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
JP2000038335A (ja) * 1998-07-22 2000-02-08 Kanebo Ltd 皮膚化粧料
WO2001014379A2 (en) 1999-08-23 2001-03-01 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2003028667A2 (en) * 2001-10-04 2003-04-10 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
DK1317921T3 (da) * 2001-12-07 2009-12-21 Besins Mfg Belgium Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf
US6695171B2 (en) * 2002-02-12 2004-02-24 Seaquistperfect Dispensing Foreign, Inc. Pump dispenser
WO2004087123A1 (en) * 2003-04-01 2004-10-14 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
WO2004054557A2 (en) * 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
DE60327363D1 (de) * 2002-12-18 2009-06-04 Besins Int Lab Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
CA2528431C (en) * 2003-06-09 2012-09-18 Northwestern University Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
EP1694319B1 (en) * 2003-12-15 2008-07-16 Laboratoires Besins International Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations

Also Published As

Publication number Publication date
PL1727532T3 (pl) 2010-06-30
CA2557806C (en) 2011-08-30
MXPA06010928A (es) 2006-12-15
US20050208139A1 (en) 2005-09-22
IL215897A (en) 2014-09-30
ES2337069T3 (es) 2010-04-20
NO20064765L (no) 2006-10-20
WO2005092310A3 (en) 2005-12-01
EP1727532A2 (en) 2006-12-06
WO2005092310A2 (en) 2005-10-06
AR048587A1 (es) 2006-05-10
TWI401078B (zh) 2013-07-11
PT1727532E (pt) 2010-03-30
AU2005227073A1 (en) 2005-10-06
JP5489407B2 (ja) 2014-05-14
RU2006137282A (ru) 2008-04-27
JP2007530498A (ja) 2007-11-01
IL177778A0 (en) 2006-12-31
TW200533334A (en) 2005-10-16
NO337298B1 (no) 2016-03-07
EP1579857A1 (en) 2005-09-28
CN101080222A (zh) 2007-11-28
EP2147670B1 (en) 2014-10-01
IL215897A0 (en) 2011-12-29
EP2269599A1 (en) 2011-01-05
CN101080222B (zh) 2013-08-07
EP2269599B1 (en) 2013-02-20
DE602005018613D1 (de) 2010-02-11
ES2402921T3 (es) 2013-05-10
ATE453387T1 (de) 2010-01-15
DK1727532T3 (da) 2010-05-03
CA2557806A1 (en) 2005-10-06
NZ549664A (en) 2011-01-28
AU2005227073B2 (en) 2011-06-23
RU2389483C2 (ru) 2010-05-20
ZA200607291B (en) 2008-04-30
EP2147670A1 (en) 2010-01-27
EP1727532B1 (en) 2009-12-30
HK1098674A1 (en) 2007-07-27
IL177778A (en) 2011-12-29
ES2517894T3 (es) 2014-11-04

Similar Documents

Publication Publication Date Title
HK1139332A1 (en) Chemically stable compositions of 4-hydroxy tamoxifen 4-
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
EG24416A (en) Amitraz compositions
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
EP1718714A4 (en) COMPOSITIONS CONTAINING A PLOTTER
GB0501192D0 (en) Stable prostaglandin-containing compositions
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
EP1786437A4 (en) IMPROVED GHB COMPOSITIONS
ZA200904425B (en) Nemathical compositions
ZA200703016B (en) 4-Hydroxy tamoxifen gel formulations
IL176934A0 (en) Modafinil compositions
IL186673A0 (en) Stable emulsion composition
FI20050195A (fi) Metalliseoksen käyttö
GB0405406D0 (en) Anti-vaginitis compositions
ZA200704741B (en) Altering properties of fuel compositions
GB0504924D0 (en) Perfume compositions
GB0723011D0 (en) Fragrance compositions
GB0505702D0 (en) Perfume compositions
GB0519437D0 (en) Perfume compositions
IL186606A0 (en) Compositions and uses of amooranin compounds
GB0512715D0 (en) Fragrance compositions
ZA200701197B (en) Compositions
ZA200702874B (en) Amitraz compositions
GB0410140D0 (en) Compositions
GB0425445D0 (en) Novel compositions